O-116 Scandinavian randomised trial of neoadjuvant chemotherapy in NSCLC stages IB-IIIA
Jakob B. Sørensen(University of Copenhagen), U. Aaseboe(Aarhus Municipality), Carsten Rytter(Aarhus Municipality), Torben Palshof(Aarhus Municipality), Olfred Hansen(Aarhus Municipality), Jesper Ravn(Akershus University Hospital), K. Mattson(Asklepios Fachkliniken München-Gauting), Han Kristian Pilegaard, H. Riska(Aarhus Municipality), Lars Ladegaard(Aarhus Municipality)
Cited by 0
Related Papers
Randomized, Multinational, Phase III Study of Docetaxel Plus Platinum Combinations Versus Vinorelbine Plus Cisplatin for Advanced Non–Small-Cell Lung Cancer: The TAX 326 Study Group
|Journal of Clinical Oncology|2003|943
Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2000|719
Differential Control of the Releasable Vesicle Pools by SNAP-25 Splice Variants and SNAP-23
|Cell|2003|369
Sequential N‐ to C‐terminal SNARE complex assembly drives priming and fusion of secretory vesicles
|The EMBO Journal|2006|310